Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

3.

Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.

Kadoyama K, Kuwahara A, Yamamori M, Brown JB, Sakaeda T, Okuno Y.

J Exp Clin Cancer Res. 2011 Oct 5;30:93. doi: 10.1186/1756-9966-30-93.

4.

Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS.

Tamura T, Sakaeda T, Kadoyama K, Okuno Y.

Int J Med Sci. 2012;9(6):441-6. doi: 10.7150/ijms.4549. Epub 2012 Jul 25.

6.

Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system.

Sakaeda T, Kadoyama K, Okuno Y.

PLoS One. 2011;6(12):e28124. doi: 10.1371/journal.pone.0028124. Epub 2011 Dec 20.

7.

Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System.

Tamura T, Sakaeda T, Kadoyama K, Okuno Y.

Int J Med Sci. 2012;9(5):322-6. doi: 10.7150/ijms.4397. Epub 2012 Jun 13.

8.

Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS.

Sakaeda T, Kadoyama K, Yabuuchi H, Niijima S, Seki K, Shiraishi Y, Okuno Y.

Int J Med Sci. 2011;8(4):332-8. Epub 2011 May 21.

9.

Data mining of the public version of the FDA Adverse Event Reporting System.

Sakaeda T, Tamon A, Kadoyama K, Okuno Y.

Int J Med Sci. 2013 Apr 25;10(7):796-803. doi: 10.7150/ijms.6048. Print 2013. Review.

11.

Commonality of drug-associated adverse events detected by 4 commonly used data mining algorithms.

Sakaeda T, Kadoyama K, Minami K, Okuno Y.

Int J Med Sci. 2014 Mar 15;11(5):461-5. doi: 10.7150/ijms.7967. eCollection 2014.

13.

Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profiles.

Bailey S, Singh A, Azadian R, Huber P, Blum M.

Drug Saf. 2010 Feb 1;33(2):139-46. doi: 10.2165/11319000-000000000-00000.

PMID:
20082540
14.

A survey of the FAERS database concerning the adverse event profiles of α1-adrenoreceptor blockers for lower urinary tract symptoms.

Yoshimura K, Kadoyama K, Sakaeda T, Sugino Y, Ogawa O, Okuno Y.

Int J Med Sci. 2013 May 15;10(7):864-9. doi: 10.7150/ijms.5892. Print 2013.

15.

Capecitabine for the treatment for advanced gastric cancer: efficacy, safety and ethnicity.

Ma Y, Tang L, Wang HX, Xu YC, Ma Y, Zhang FC.

J Clin Pharm Ther. 2012 Jun;37(3):266-75. doi: 10.1111/j.1365-2710.2011.01289.x. Epub 2011 Sep 26. Review.

PMID:
21950464
16.

Capecitabine: a review.

Walko CM, Lindley C.

Clin Ther. 2005 Jan;27(1):23-44. Review.

PMID:
15763604
17.

Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).

DuMouchel W, Fram D, Yang X, Mahmoud RA, Grogg AL, Engelhart L, Ramaswamy K.

Ann Clin Psychiatry. 2008 Jan-Mar;20(1):21-31. doi: 10.1080/10401230701844612.

PMID:
18297583
18.

Cardiovascular thromboembolic events associated with febuxostat: investigation of cases from the FDA adverse event reporting system database.

Gandhi PK, Gentry WM, Bottorff MB.

Semin Arthritis Rheum. 2013 Jun;42(6):562-6. doi: 10.1016/j.semarthrit.2012.11.002. Epub 2013 Jan 24.

PMID:
23352248
19.

Lamotrigine and aseptic meningitis.

Simms KM, Kortepeter C, Avigan M.

Neurology. 2012 Mar 20;78(12):921-7. doi: 10.1212/WNL.0b013e31824c4634. Epub 2012 Feb 22.

PMID:
22357718
20.

Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS).

Poluzzi E, Raschi E, Moretti U, De Ponti F.

Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):512-8. doi: 10.1002/pds.1746.

PMID:
19358226
Items per page

Supplemental Content

Write to the Help Desk